Piriformis Syndrome; Extracorporeal Shock Wave Therapy and Dry Needling

Not Applicable

Completed

• Conditions: Piriformis Syndrome; Extracorporeal Shock Wave Therapy

• Registration Number: NCT06530862
• Lead Sponsor: Istanbul Training and Research Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-7-27
• Last Update Posted: 23 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Inclusion Criteria:<br><br> - >18 years<br><br> - Complaint for more than 3 months<br><br>Exclusion Criteria:<br><br> - disc pathologies according to radiological imaging<br><br> - hip joint and soft tissue pathologies<br><br> - recent history of trauma, history of surgery in the lumbar and hip region<br><br> - history of rheumatologic disease<br><br> - history of polyneuropathy<br><br> - history of sciatic nerve injury<br><br> - history of malignancy<br><br> - opioid analgesia or corticosteroid intervention for pain in the last month<br><br> - patients receive another treatment during the study<br><br> - Having a contraindication for DN treatment or ESWT treatment

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analog scale (VAS) score;Lower extremity functiunal scale (LEFS);Oswestry disability index (ODI)